Granulocyte-macrophage colony-stimulating factor (GM-CSF) decreases left ventricular function. An echocardiographic study in cancer patients

Cytokine

Volumn 14, Issue 3, 2001, Pages 184-187

  Knoops, Saskia ^a   Groeneveld, A B Johan ^a   Kamp, Otto ^a   Lagrand, Wim K ^a   Hoekman, Klaas ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Advanced breast cancer; Advanced sarcoma; Cardiac function; Effect of cytokines; Haematopoietic growth factors; Left ventricular dimensions

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL ARTICLE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HUMAN; MALE; PRIORITY JOURNAL; SARCOMA;

EID: 0035820615     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2001.0869     Document Type: Article

References (15)

1. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor
2. Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor α in the priming of the neutrophil respiratory burst
3. GM-CSF rapidly primes mice for enhanced cytokine production in response to LPS and TNF
4. A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers
5. A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (>55 to 70 years of age) with acute myelogenous leukemia: A study of the Eastern cooperative oncology group (E1490)
6. Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: Increased efficacy and reduced toxicity when given subcutaneously
7. Serum levels of tumor necrosis factor-α in patients tested with granulocyte-macrophage colony-stimulating factor
8. Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancer
9. Tumor necrosis factor in the heart
10. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility
11. Expression of inducible nitric oxide synthase by macrophages in rat lung
12. Myocardial dysfunction in sepsis: Mechanisms and therapeutic implications
13. Cellular basis for the acute inhibitory effects of IL-6 and TNF-α on excitation-contraction coupling
14. Recommendations regarding quantification in M-mode echocardiography
15. Noninvasive Doppler determination of cardiac output in man